Suppr超能文献

制备规模纯化岩藻糖基-N-乙酰葡萄糖胺二糖及其作为潜在益生元和抗黏附剂的评价。

Preparative scale purification of fucosyl-N-acetylglucosamine disaccharides and their evaluation as potential prebiotics and antiadhesins.

机构信息

Laboratorio de Bacterias Lácticas y Probióticos, Departamento de Biotecnología de Alimentos, IATA-CSIC, Av. Agustín Escardino 7, 46980, Paterna, Valencia, Spain.

出版信息

Appl Microbiol Biotechnol. 2015 Sep;99(17):7165-76. doi: 10.1007/s00253-015-6666-2. Epub 2015 May 16.

Abstract

Fucosyl-N-acetylglucosamine disaccharides are important core structures that form part of human mucosal and milk glyco-complexes. We have previously shown that AlfB and AlfC α-L-fucosidases from Lactobacillus casei are able to synthesize fucosyl-α-1,3--N-acetylglucosamine (Fuc-α1,3-GlcNAc) and fucosyl-α-1,6-N-acetylglucosamine (Fuc-α1,6-GlcNAc), respectively, in transglycosylation reactions. Here, these reactions were performed in a semipreparative scale, and the produced disaccharides were purified. The maximum yields obtained of Fuc-α1,3-GlcNAc and Fuc-α1,6-GlcNAc were 4.2 and 9.3 g/l, respectively. The purified fucosyl-disaccharides were then analyzed for their prebiotic effect in vitro using strains from the Lactobacillus casei/paracasei/rhamnosus group and from Bifidobacterium species. The results revealed that 6 out of 11 L. casei strains and 2 out of 6 L. rhamnosus strains tested were able to ferment Fuc-α1,3-GlcNAc, and L. casei BL87 and L. rhamnosus BL327 strains were also able to ferment Fuc-α1,6-GlcNAc. DNA hybridization experiments suggested that the metabolism of Fuc-α1,3-GlcNAc in those strains relies in an α-L-fucosidase homologous to AlfB. Bifidobacterium breve and Bibidobacterium pseudocatenolatum species also metabolized Fuc-α1,3-GlcNAc. Notably, L-fucose was excreted from all the Lactobacillus and Bifidobacterium strains fermenting fucosyl-disaccharides, except from strains L. rhamnosus BL358 and BL377, indicating that in these latest strains, L-fucose was catabolized. The fucosyl-disaccharides were also tested for their inhibitory potential of pathogen adhesion to human colon adenocarcinoma epithelial (HT29) cell line. Enteropathogenic Escherichia coli (EPEC) strains isolated from infantile gastroenteritis were used, and the results showed that both fucosyl-disaccharides inhibited adhesion to different extents of certain EPEC strains to HT29 cells in tissue culture.

摘要

岩藻糖基-N-乙酰氨基葡萄糖二糖是构成人类黏膜和乳聚糖复合物的重要核心结构。我们之前已经表明,来自干酪乳杆菌的 AlfB 和 AlfC α-L-岩藻糖苷酶能够分别在转糖苷反应中合成岩藻糖-α1,3--N-乙酰氨基葡萄糖(Fuc-α1,3-GlcNAc)和岩藻糖-α1,6-N-乙酰氨基葡萄糖(Fuc-α1,6-GlcNAc)。在这里,这些反应在半制备规模下进行,并且产生的二糖被纯化。获得的 Fuc-α1,3-GlcNAc 和 Fuc-α1,6-GlcNAc 的最大产量分别为 4.2 和 9.3 g/L。然后,使用来自干酪乳杆菌/副干酪乳杆菌/鼠李糖乳杆菌组和双歧杆菌属的菌株,在体外分析了纯化的岩藻糖二糖的益生元作用。结果表明,在所测试的 11 株干酪乳杆菌菌株中有 6 株和 6 株干酪乳杆菌菌株中有 2 株能够发酵 Fuc-α1,3-GlcNAc,而干酪乳杆菌 BL87 和干酪乳杆菌 BL327 菌株也能够发酵 Fuc-α1,6-GlcNAc。DNA 杂交实验表明,这些菌株中 Fuc-α1,3-GlcNAc 的代谢依赖于与 AlfB 同源的α-L-岩藻糖苷酶。短双歧杆菌和假双歧杆菌物种也代谢 Fuc-α1,3-GlcNAc。值得注意的是,除了干酪乳杆菌 BL358 和 BL377 菌株外,所有发酵岩藻糖二糖的乳杆菌和双歧杆菌菌株都排出了 L-岩藻糖,表明在这些最后一批菌株中,L-岩藻糖被代谢掉了。还测试了岩藻糖二糖对人结肠腺癌细胞系(HT29)上病原体粘附的抑制潜力。使用了从婴儿肠胃炎中分离出的肠致病性大肠杆菌(EPEC)菌株,结果表明,这两种岩藻糖二糖都在不同程度上抑制了某些 EPEC 菌株对 HT29 细胞的粘附。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验